Menopause money
Factory Capital targets USD350b menopause market starved of institutional capital.
Good Morning.
An up to USD350 billion global market with virtually no institutional capital deployed into it. That is the opportunity Factory Capital says it is trying to unlock in women’s “midlife” health.
Managing director Anna Samuelsson told Capital Brief’s Hugo Mathers the peri- and post-menopause sector is so fragmented that investors cannot efficiently allocate to it, and her solution is to build the clinical infrastructure first (think treatment protocols, care pathways and clinician training) housed in a new Austin-based non-profit, before backing businesses that can commercialise on top of it.
“What we’re really doing is creating a market,” Samuelsson said.
| ▲ | ASX 200 | 8,657 | +0.41% |
| ▼ | ASX futures | 8,627 | -0.67% |
| ▲ | S&P 500 | 7,473 | +0.37% |
| ▲ | NASDAQ | 26,344 | +0.19% |
| ▲ | AUD/USD | 0.72 | +0.20% |
| ▲ | Bitcoin | 76,646 | +0.99% |
ASX 200 as at market close. Bitcoin in USD.
Market movers
| ▲ | ASX:GYG | $19.81 | +9.57% |
Shares in Guzman y Gomez, the Mexican fast-food chain that has spent three months trying to revive a stuttering US expansion, surged on Friday after co-CEO Steven Marks called time on the project, announcing the immediate closure of all eight Chicago restaurants and the laying off of 280 staff. RBC Capital Markets analyst Michael Toner said the exit was a positive, arguing the US business had “very low prospects of being successful” and that its losses had been weighing on the group’s earnings.
“We have not always got things right and we have learned a lot,” Marks, who had been on the ground in Chicago since February, told Capital Brief.
